New Clinical Trial for Bone Metastatic PCa

New Topic Post Reply Printable Version
[ << Previous Thread | Next Thread >> ]

Sonny3
Veteran Member


Date Joined Aug 2009
Total Posts : 2447
   Posted 11/24/2009 8:14 AM (GMT -6)   
Saw this on another site and thought it might be of interest here. I had not seen reference to the trial here on HW before. It is a clinical trial being conducted in the US and other countries for brothers suffering metastatic PCa.

http://www.news-medical.net/news/20091118/Phase-III-randomized-clinical-trial-for-Alpharadin-to-be-commenced.aspx

Sonny
61 years old
PSA 11/07 3.0
PSA 5/09 6.4
Diagnosis confirmed July 9, 2009
12 Needle Biopsy = 9 clear , 3 postive
<5%, 90%, 40%
Gleason Score (3+4) 7 in all positive cores
CT Organ Scan - negative
Nuclear Bone Scan - Negative
da Vinci 9/17/09
Post Surgery Pathology:
Gleason: Changed to (4+3) = 7
Stage: T3a
Tumor Volume 12.5%
NERVES SPARED-positive margin, extra-prostatic extension
30 day PSA 0.4, 50 day psa 0.53, 64 day psa 0.6
IMRT scheduled to begin Nov 30,2009 (74 days post surgery)

New Topic Post Reply Printable Version
Forum Information
Currently it is Sunday, July 22, 2018 7:32 PM (GMT -6)
There are a total of 2,984,365 posts in 327,214 threads.
View Active Threads


Who's Online
This forum has 161991 registered members. Please welcome our newest member, LIssah40.
398 Guest(s), 7 Registered Member(s) are currently online.  Details
Jkm97, BuckeyeSDH, Saipan Paradise, InTheShop, Nacho Libre, ltc1225, moleUC